HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

Larotrectinib Sulfate

HCID 67330085
New reaction
Print

Completing data — refresh the page later to see the latest

Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
1223405-08-0
Standard SMILES
O=C(Nc1cnn2ccc(N3CCC[C@@H]3c3cc(F)ccc3F)nc12)N1CC[C@H](O)C1.O=S(=O)(O)O
InChIKey
PXHANKVTFWSDSG-QLOBERJESA-N
Molecular formula
C21H24F2N6O6S
Average molar mass
526.5 g/mol
Monoisotopic mass
526.14460993

Overview

Larotrectinib Sulfate is the sulfate salt form of larotrectinib, an orally available, tropomyosin receptor kinase (Trk) inhibitor, with potential antineoplastic activity. Upon administration, larotrectinib binds to Trk, thereby preventing neurotrophin-Trk interaction and Trk activation, which results in both the induction of cellular apoptosis and the inhibition of cell growth in tumors that overexpress Trk. Trk, a receptor tyrosine kinase activated by neurotrophins, is mutated in a variety of cancer cell types and plays an important role in tumor cell growth and survival.

Names & identifiers

Preferred name
Larotrectinib Sulfate
IUPAC
(3S)-N-[5-[(2R)-2-(2,5-difluorophenyl)pyrrolidin-1-yl]pyrazolo[1,5-a]pyrimidin-3-yl]-3-hydroxypyrrolidine-1-carboxamide;sulfuric acid
English name
Larotrectinib Sulfate
Molecular formula
C21H24F2N6O6S
Molecular weight
526.52

Names & synonyms

Larotrectinib sulfate1223405-08-0LOXO-101 sulfateARRY-470 sulfateRDF76R62IDUNII-RDF76R62ID1-Pyrrolidinecarboxamide, N-[5-[(2R)-2-(2,5-difluorophenyl)-1-pyrrolidinyl]pyrazolo[1,5-a]pyrimidin-3-yl]-3-hydroxy-, (3S)-, sulfate (1:1)1-Pyrrolidinecarboxamide, N-(5-((2R)-2-(2,5-difluorophenyl)-1-pyrrolidinyl)pyrazolo(1,5-a)pyrimidin-3-yl)-3-hydroxy-, (3S)-, sulfate (1:1)(3S)-N-(5-((2R)-2-(2,5-DIFLUOROPHENYL)PYRROLIDIN-1-YL)PYRAZOLO(1,5-A)PYRIMIDIN-3-YL)-3-HYDROXYPYRROLIDINE-1-CARBOXAMIDE SULFATE (1:1)(3S)-N-{5-[(2R)-2-(2,5-Difluorophenyl)pyrrolidin-1-yl]pyrazolo[1,5-a]pyrimidin-3-yl}-3-hydroxypyrrolidine-1-carboxamide sulfate (1:1)LOXO 101 sulfateARRY 470 Sulfate
Show more names
(3S)-N-[5-[(2R)-2-(2,5-Difluorophenyl)-1-pyrrolidinyl]pyrazolo[1,5-a]pyrimidin-3-yl]-3-hydroxy-1-pyrrolidinecarboxamide sulfate (1:1)LOX-101Loxo-101(S)LOX-101(sulfate)ARRY 470) sulfateLarotinib sulfateLarotrectinib(LOXO 101
RefChem:57160(3S)-N-(5-((2R)-2-(2,5-Difluorophenyl)pyrrolidin-1-yl)pyrazolo(1,5-a)pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide monosulfateLOXO-101 (sulfate)(S)-N-(5-((R)-2-(2,5-difluorophenyl)pyrrolidin-1-yl)pyrazolo[1,5-a]pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide sulfateLarotrectinib sulfate [USAN](3S)-N-[5-[(2R)-2-(2,5-difluorophenyl)pyrrolidin-1-yl]pyrazolo[1,5-a]pyrimidin-3-yl]-3-hydroxypyrrolidine-1-carboxamide;sulfuric acidEX-A1981A(3S)-N-[5-[(2R)-2-(2,5-Difluorophenyl)-1-pyrrolidinyl]pyrazolo[1,5-a]pyrimidin-3-yl]-3-hydroxy-1-pyrrolidinecarboxamide sulfate

Properties

Computed structural propertiesFilling in

Topological polar surface area
169 Ų
Hydrogen bond donors
4
Hydrogen bond acceptors
11
Rotatable bonds
3
Heavy atoms
36
Formal charge
0
Complexity
741

Experimental & physicochemical properties

Human Drugs · 3 items

FDA approved drugs -> Active ingredient

EMA approved medicines: Human medicine

FDA approved drugs -> Active ingredient

Physicochemical properties

storage temp.
-20 °C · Store at -20°C
solubility
18.47 mg/mL · ≥18.47 mg/mL in DMSO; ≥2.14 mg/mL in EtOH; ≥29.65 mg/mL in H2O
form
solid
color
Light yellow to brown
Stability
Hygroscopic
InChIKey
PXHANKVTFWSDSG-RZOMTXEQNA-N
SMILES
S(O)(O)(=O)=O.FC1C=CC(F)=CC=1[C@H]1CCCN1C1C=CN2N=CC(NC(N3C[C@@H](O)CC3)=O)=C2N=1 |&1:13,29,r|
FDA UNII
76 R62ID · RDF76R62ID
NCI Dictionary of Cancer Terms
larotrectinib sulfate
NCI Drug Dictionary
larotrectinib sulfate
Symbol(GHS)

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

GHS classification

GHS Classification · 4 items

Warning

H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]

P260, P264, P270, P301+P317, P319, P330, and P501 (click each P-code to see the statement)

The GHS information provided by 1 company from 1 notification to the ECHA C&L Inventory.

Hazard information

Hazard Classes and CategoriesAcute Tox. 4 (100%)

Toxicology

Drug Induced Liver Injury · 6 items

Drug Induced Liver Injury Rank (DILIrank 2.0)

Larotrectinib sulfate

Ambiguous-DILI-concern

3

Warnings & precautions

DOI:10.1016/j.drudis.2016.02.015

Safety data

Signal word
Warning
Symbol(GHS)
GHS07
Hazard statements
H302-H315-H319-H335
Precautionary statements
P261-P305+P351+P338

Chemistry & industry

Applications

DescriptionLOXO-101 (sulfate) (or Larotrectinib Sulfate) is an oral potent and selective ATP-competitive inhibitor of tropomyosin receptor kinases (TRK).

UsesLarotrectinib Sulfate is a potent and selective oral ATP-competitive inhibitor of tropomyosin receptor kinases (TRK).

Upstream & downstream products

Upstream raw materials

4H-Pyrazolo[1,5-a]pyrimidin-5-one(S)-3-Hydroxypyrrolidine5-(2,5-difluorophenyl)-3,4-dihydro-2H-pyrrole3-nitropyrazolo[1,5-a]pyrimidin-5(4H)-oneLOXO-101(S)-3-Hydroxypyrrolidine hydrochloride(R)-5-(2-(2,5-difluorophenyl)pyrrolidin-1-yl)-3-nitropyrazolo[1,5-a]pyrimidine(R)-5-(2-(2,5-difluorophenyl)pyrrolidin-1-yl)pyrazolo[1,5-a]pyrimidin-3-amine(2R)-2-(2,5-Difluorophenyl)pyrrolidine1-Bromo-2,5-difluorobenzene

Related reactions

4 records
New reaction record
HRID 63999 reaction equation
HRID 63999As product
HRID 537775 reaction equation
HRID 537775As product
HRID 1893783 reaction equation
HRID 1893783As product
HRID 2275351 reaction equation
HRID 2275351As product

Compound notes

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes

Database identifiers

CAS
1223405-08-0
PubChem CID
67330085
DTXSID
DTXSID401026485
ChEMBL
CHEMBL3989939
UNII
RDF76R62ID
EC Number
185-359-2
7 · GHS07
Signal word
Warning
Hazard statements
302 · H302-H315-H319-H335
Precautionary statements
261 · P261-P305+P351+P338